NUR 5213 Module 4 Patient Education Tool Example

Thigh, Not Thumb: A Patient Education Tool on the Epinephrine Auto-Injector for a 14-Year-Old With Peanut Allergy and the Adults Around Him, Scored With the PEMAT

Student Name

American College of Education

NUR5213: Advanced Pharmacology for Health Educators

Module 4 Assignment

Instructor Name

March 28, 2028

The Medication and Why It Is High Risk

Epinephrine is the first-line treatment for anaphylaxis, and delay in giving it is a consistent feature of fatal reactions. The current practice parameter on anaphylaxis names an intramuscular injection of epinephrine, given without delay, as the first treatment, and advises that patients at risk carry auto-injectors and have a written emergency action plan (Shaker et al., 2020). The pharmacology explains the urgency. Anaphylaxis releases mediators such as histamine that dilate blood vessels, make them leak and constrict the airways. Epinephrine acts on alpha-1 receptors to constrict blood vessels and raise blood pressure, on beta-1 receptors to strengthen the heartbeat, and on beta-2 receptors to relax the airways; it also reduces further mediator release. No other drug does all of these at once. Antihistamines relieve itching and hives but do not reverse low blood pressure or airway narrowing, which is why using them first can waste critical minutes.

The drug itself is safe in the dose delivered by an auto-injector for most young people, but the device is high risk because it is used rarely, under stress, by someone who may be frightened or ill. Injecting into the thumb, which can happen when a user grips the device the wrong way round, can cut off blood flow to the finger. Injecting too briefly or into the wrong site reduces absorption. The American Academy of Pediatrics' report on epinephrine for first-aid management of anaphylaxis emphasizes injection into the mid-outer thigh and education of children and supervising adults in recognizing reactions and using the device (Sicherer et al., 2017).

The Audience and Their Needs

The tool is written for a composite 14-year-old boy with peanut allergy who had anaphylaxis at a friend's house and was seen in the emergency department of the hospital where the author teaches, and for his parents and grandmother, who care for him after school. Adolescents with food allergy are at particular risk because they eat away from home more, may not carry their auto-injectors, and may be reluctant to use them in front of friends. The boy's family had an auto-injector at home but did not have one with him, and no one at the friend's house knew where it should go. His grandmother reads English at a basic level and prefers pictures. The tool therefore needs to be short, pictorial, action-focused and usable by both a teenager and an older adult under stress.

The Tool

Title: Your Epinephrine Pen Saves Your Life. Use It Fast.

Box 1. When to use it. Use your pen right away if you ate peanut, or think you did, and you have ANY of these: trouble breathing, wheezing or coughing that will not stop; throat tight or hoarse voice; lips or tongue swelling; feeling faint, dizzy or very sleepy; vomiting many times; hives all over your body with any other sign. Do not wait to see if it gets better. Do not take an allergy pill first.

Box 2. How to use it. One: Take off the safety cap. Two: Hold the pen in your fist with the tip pointing down, away from your thumb. Three: Push the tip hard into the outer middle of your thigh. You can go through clothes. Four: Hold it there and count slowly to three. Five: Pull it out and rub the spot.

Box 3. Right after. Call 911 and say anaphylaxis. Lie down with your legs up, or sit up if it is hard to breathe. If you are not better in 5 to 15 minutes, or you get worse, use your second pen. Still go to the hospital when you feel better. The reaction can return.

Box 4. Every day. Carry two pens with you, everywhere, even to a friend's house. Keep them at room temperature, not in a hot car. Check the date on your pens every month. Tell your friends where your pens are and how to use them.

What the Tool Leaves Out, and Why

A tool for a high-risk medication is defined as much by what it omits as by what it includes. The first draft contained a paragraph explaining how epinephrine works on blood vessels and airways, taken from the pharmacology above. It was removed. The family needs to act on that knowledge, not recite it, and the explanation belongs in the conversation with the nurse, where questions can be answered, rather than on a page to be read during an emergency. The draft also listed the brand names of several auto-injectors with slightly different instructions. That was replaced by a single sequence that works for the family's own device, with a note to ask the pharmacist if the device changes at a refill, because a family confused by alternatives under stress is more likely to freeze. Dose information was left out entirely, since the dose is fixed by the prescription and the device, and discussing it would invite the family to wonder whether to give half a pen or wait. Finally, the list of symptoms in the first box was shortened to those most likely to indicate anaphylaxis and phrased in words the teenager used himself when describing his reaction, such as throat tight, rather than clinical terms such as angioedema or stridor. Each omission was tested by asking whether the family would do anything differently without it; if the answer was no, it stayed out.

Evaluating the Tool

The Patient Education Materials Assessment Tool for printable materials was used to score the tool, which rates understandability and actionability. In its development study, materials rated as more actionable led to better comprehension among consumers (Shoemaker et al., 2014). The author and a second nurse educator rated the tool independently. Understandability scored 92%: it uses common words, short sections with headings, active voice and a clear purpose; the one item missed was the absence of a summary. Actionability scored 100%: every section states at least one action, breaks it into steps and uses a visual aid, since each box is paired with a simple drawing of the step. The reading level, measured with a standard readability formula, was about grade 6. After rating, a one-line summary was added at the bottom: Fast pen, thigh, 911, second pen if needed, always carry two.

Teaching and Checking

The tool is not handed out alone. Before discharge, the nurse uses it with the teenager and each caregiver, one at a time, with a trainer device that has no needle. Each person practices the full sequence, including removing the cap, positioning the thumb away from the tip, pressing into the thigh and holding. The nurse then uses teach-back, asking each person to explain when they would use the pen and what they would do next, and corrects any step that is missed. The teenager is also asked to role-play telling a friend where his pens are, since that conversation is often the hardest part for adolescents. The family receives two trainer devices and is asked to practice monthly. At the allergy clinic follow-up, the nurse checks technique again and asks whether he has carried both pens every day since discharge, which is the behavior the tool is ultimately meant to change.

References

Shaker, M. S., Wallace, D. V., Golden, D. B. K., Oppenheimer, J., Bernstein, J. A., Campbell, R. L., Dinakar, C., Ellis, A., Greenhawt, M., Khan, D. A., Lang, D. M., Lang, E. S., Lieberman, J. A., Portnoy, J., Rank, M. A., Stukus, D. R., Wang, J., Riblet, N., Bobrownicki, A. M. P., ... Wang, J. (2020). Anaphylaxis: A 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. Journal of Allergy and Clinical Immunology, 145(4), 1082-1123. https://doi.org/10.1016/j.jaci.2020.01.017

Shoemaker, S. J., Wolf, M. S., & Brach, C. (2014). Development of the Patient Education Materials Assessment Tool (PEMAT): A new measure of understandability and actionability for print and audiovisual patient information. Patient Education and Counseling, 96(3), 395-403. https://doi.org/10.1016/j.pec.2014.05.027

Sicherer, S. H., Simons, F. E. R., & Section on Allergy and Immunology. (2017). Epinephrine for first-aid management of anaphylaxis. Pediatrics, 139(3), Article e20164006. https://doi.org/10.1542/peds.2016-4006